Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vtama
Pharma
Organon pays up to $1.2B to acquire Dermavant and its drug Vtama
With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a potential blockbuster in tow.
Fraiser Kansteiner
Sep 18, 2024 10:09am
Dermavant's Vtama excels in another trial in atopic dermatitis
Jan 11, 2024 10:46am
Dermavant CEO draws Botox comparison to instill Vtama confidence
Nov 28, 2023 4:10pm
With Dermavant's Vtama struggling, Leerink slashes projections
Nov 14, 2023 11:13am
Dermavant strengthens approval bid for Vtama in eczema
Oct 12, 2023 8:50am
Dermavant bolsters Vtama's case for approval in eczema
May 16, 2023 8:25am
